Programmatic in Pharma: A Glossary of the Terms That Matter
A plain glossary of programmatic in pharma: 45 terms on buying, HCP and DTC audiences, compliance, quality, and measurement, each defined in a sentence or two.
The short answer
Programmatic in pharma is automated digital media buying, through DSPs, exchanges, and private deals, used to reach healthcare professionals and patients. Most of the vocabulary is shared with other categories. The pharma-specific terms cluster around audiences (NPI, match rate, condition segments), compliance (MLR, ISI, fair balance), and measurement (exposure files, holdouts, NBRx).
This glossary is for people who sit in pharma media meetings and keep hearing the same twenty acronyms. Definitions are short on purpose. Where a term deserves more, there is a link to a longer piece. For how the pieces fit together, start with the guide to programmatic advertising in healthcare.
Buying and platforms: programmatic media for pharma basics
| Term | What it means |
|---|---|
| DSP (demand-side platform) | The software buyers use to bid on impressions across many exchanges from one place. The DSP holds targeting, budgets, and bid logic. |
| SSP (supply-side platform) | The publisher's side of the trade. It packages impressions and sends bid requests to DSPs. Most SSPs now run their own exchange, so the two words are often used interchangeably. |
| Open auction | Inventory any buyer can bid on. Cheapest on average, least control over where ads run. |
| PMP (private marketplace) | An invitation-only auction with selected buyers, usually with a price floor. Common for health publishers. |
| Programmatic guaranteed | A fixed price and fixed volume deal executed through the DSP. Behaves like a direct buy with automated delivery. |
| Deal ID | The identifier that tells the DSP a bid request belongs to a specific PMP or guaranteed deal. |
| CPM | Cost per thousand impressions. The standard price unit, and a poor predictor of outcome cost on its own. |
| Bid floor | The minimum price a seller will accept. Floors in health PMPs are often well above open auction averages. |
| Pacing | How evenly a budget is spent across a flight. Underpacing and overpacing both signal a setup or supply problem. |
| Frequency cap | A limit on how often one user or device sees an ad in a set period. With small HCP audiences, caps bind quickly. |
Audience and identity terms
| Term | What it means |
|---|---|
| NPI | National Provider Identifier, the 10-digit number every US healthcare provider who bills uses. It is the anchor for HCP target lists. See the NPI targeting guide. |
| HCP | Healthcare professional. Includes physicians, nurse practitioners, physician assistants, pharmacists, and others, depending on the brand's definition. |
| Target list | The set of NPIs a brand wants to reach, usually ranked by decile or tier. |
| Decile | A ranking of prescribers into ten groups by prescription volume in a market. Decile 10 is usually the highest volume. |
| Match rate | The share of a target list a partner can tie to digital identifiers. A high number is not proof of accuracy. |
| Identity graph | A database linking identifiers (emails, devices, cookies, IDs) to a person or household, or to an NPI. |
| Onboarding | Converting an offline list (NPIs, CRM records) into addressable digital IDs. |
| Condition audience | A consumer segment assumed to have, or be interested in, a health condition. Needs provenance and state-law review. |
| Contextual targeting | Choosing impressions by the content of the page or video, not by who the viewer is. |
| Endemic media | Publishers and platforms whose content is medical or health focused, such as medical news sites, EHRs, and point-of-care networks. |
| Lookalike | An audience modeled to resemble a seed group. Often restricted in health because the seed itself may be sensitive data. |
| Data clean room | A controlled environment where two parties can match and analyze data without exchanging raw records. |
Compliance terms every pharma media buyer hears
| Term | What it means |
|---|---|
| MLR | Medical, legal, and regulatory review. Every creative and many media decisions need its approval. |
| OPDP | FDA's Office of Prescription Drug Promotion, which oversees prescription drug advertising and issues untitled and warning letters. |
| Fair balance | The requirement that risk information be presented with comparable prominence to benefit claims. |
| ISI | Important safety information. The risk section that accompanies product claim ads, often as a scrolling panel in display. |
| Major statement | The disclosure of the most important risks that must appear in broadcast (TV and radio) prescription drug ads. |
| Product claim ad | An ad that names the drug and what it treats. Requires fair balance and risk information. |
| Reminder ad | Names the drug but makes no claim about use. Not permitted for drugs with a boxed warning. |
| Unbranded (help-seeking) ad | Discusses a condition without naming a product. Often used where branded rules make a format impractical. |
| Boxed warning | FDA's most serious label warning. It affects which ad types and formats a brand can use. |
Quality and supply chain terms
| Term | What it means |
|---|---|
| ads.txt | A public file where publishers list who is authorized to sell their inventory. |
| sellers.json | A file where SSPs and exchanges disclose the sellers they represent, so buyers can trace a path. |
| SPO (supply path optimization) | Cutting redundant or low-value routes to the same inventory. |
| IVT (invalid traffic) | Impressions not generated by real humans, or generated in ways that should not count. MRC guidelines split it into general and sophisticated. |
| Viewability | Whether an ad had a chance to be seen. For display, the common standard is 50 percent of pixels in view for one second. |
| MFA site | Made-for-advertising site built mainly to resell traffic, heavy on ads and light on real audience. |
| Log-level data | Impression-by-impression records from the DSP, used to audit where money went. |
The quality terms connect to a whole series of their own, starting with programmatic media quality explained.
Measurement terms
| Term | What it means |
|---|---|
| Exposure file | A record of which NPIs or hashed IDs saw which ads and when, sent to a measurement partner. |
| Holdout | A group deliberately kept from seeing ads so you can compare outcomes. See what a holdout test is. |
| Rx lift | The difference in prescribing between exposed and comparison groups, attributed to media. |
| NBRx | New-to-brand prescriptions: a patient starting the brand, whether new to therapy or switching. |
| TRx | Total prescriptions, new plus refills. |
| Attribution window | How long after exposure an outcome is still credited to the ad. |
| Incrementality | The outcomes that would not have happened without the media. Different from attributed outcomes, which may include people who would have acted anyway. |
Which terms cause the most confusion in practice
Three pairs get mixed up constantly. Match rate and accuracy: a partner can match 80 percent of your list and still be wrong about a share of those matches. Attributed and incremental: attributed counts are always larger, and presenting them as lift is the most common reporting mistake in pharma media. Reach and coverage: reaching 60 percent of a target list once is a different result from reaching it at an effective frequency. If a deck uses any of these terms without a definition, ask for one.
Practical takeaway
Copy the terms your team uses into a one-page shared glossary and attach it to the media brief, with your brand's own definitions for HCP, target list, and the outcome metric. Then point anyone new to the targeting options comparison so the audience terms have context.
Frequently asked questions
What does programmatic mean in pharma?
Programmatic in pharma means buying digital ad impressions through automated platforms (DSPs, exchanges, and deal IDs) to reach HCPs or patients. It works like programmatic in other categories, with added constraints on audience data, creative review, and measurement.
What is the difference between a PMP and open auction?
An open auction is available to any buyer on the exchange, with the clearing price set by competing bids. A private marketplace (PMP) is an invitation-only auction set up by a publisher for selected buyers, usually with a floor price and more control over where ads appear.
What is an exposure file in pharma media?
An exposure file is a record of who saw an ad, when, and in which campaign or placement, usually at the NPI or hashed identifier level. Measurement partners match it to prescribing or claims data to estimate lift.
Sources
- IAB Tech Lab, ads.txt
- IAB Tech Lab, sellers.json
- Media Rating Council, Standards and Guidelines
- eCFR, 21 CFR Part 202, Prescription Drug Advertising
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.